首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1605886

芽球性漿細胞先生樹突狀細胞腫瘤市場，規模，佔有率，趨勢，產業分析報告:不同治療，各終端用戶，各地區 - 市場預測 2025年～2034年

Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size, Share, Trends, Industry Analysis Report: By Treatment, End Users, and Region - Market Forecast, 2025-2034

出版日期: 2024年11月01日 | 出版商:

Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

根據 Polaris Market Research 的一項新研究，母細胞性漿細胞樣樹突狀細胞瘤 (BPDCN) 的市場預計到 2034 年將達到 2,828.1 億美元。該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

由於人們對該疾病的認識不斷提高以及治療方案的進步，母細胞性漿細胞樣樹突狀細胞腫瘤 (BPDCN) 市場正在經歷顯著增長。主要驅動因素包括 BPDCN 盛行率的上升以及標靶療法和創新療法的開發，包括正在擴大治療領域的新型藥物和免疫療法。

市場機會得到了正在進行的研究、臨床試驗以及旨在改善患者治療結果的個人化醫療方法的引入的支持。日益重視早期診斷和下一代定序技術整合等趨勢也預計將塑造市場。總體而言，由於這些因素著重於改善治療選擇和加強患者護理，BPDCN 市場預計將顯著成長。

母細胞樣漿細胞樣樹突細胞腫瘤市場報告重點

根據治療分析，免疫療法是成長最快的 BPDCN 市場。這是因為標靶治療和檢查點抑制劑的進步在 BPDCN 的治療中顯示出了有希望的結果。由於其有效性和副作用減少，免疫療法比傳統化療越來越受歡迎。

在最終用戶分析中，醫院憑藉先進的基礎設施和綜合的治療能力，在 BPDCN 治療市場中佔據主導地位。專科診所也在不斷增長，反映出更加重症監護並提供專業治療和患者管理的趨勢。

在先進的醫療基礎設施和大量研究活動的支持下，北美仍然是 BPDCN 最大的市場。然而，由於醫療保健投資的增加和 BPDCN 意識的增強，亞太地區成為成長最快的地區。

積極參與 BPDCN 市場的主要公司包括Stemline Therapeutics公司(現在是Menarini Group旗下)，Celgene Corporation公司(Bristol-Myers Squibb公司收購)，Pfizer Inc.公司，Johnson &Johnson公司，Novartis AG公司，Takeda Pharmaceutical公司，Amgen Inc.公司，Gilead Sciences公司，F． Hoffmann-La Roche Ltd.公司，Merck &Co., Inc.公司，AbbVie Inc.公司，AstraZeneca公司，Sanofi公司，Bayer AG公司，Incyte 有Corporation公司等。

市場概述
芽球性漿細胞先生樹突狀細胞腫瘤市場動態
- 促進因素和機會
  - 越來越多地採用標靶治療
  - 診斷技術的進步
- 抑制因素和挑戰
  - 治療費用高昂
PESTEL分析
芽球性漿細胞先生樹突狀細胞腫瘤市場終端用戶趨勢
價值鏈分析
COVID-19影響分析

第5章全球芽球性漿細胞先生樹突狀細胞腫瘤市場:不同治療

主要調查結果
簡介
化療
免疫療法
幹細胞移植

第6章全球芽球性漿細胞先生樹突狀細胞腫瘤市場:各終端用戶

主要調查結果
簡介
醫院
專門診所
其他

第7章全球芽球性漿細胞先生樹突狀細胞腫瘤市場:各地區

主要調查結果
簡介
- 芽球性漿細胞先生樹突狀細胞腫瘤市場評估:各地區，2020～2034年
北美
- 北美:不同治療，2020～2034年
- 北美:各終端用戶，2020～2034年
- 美國
- 加拿大
歐洲
- 歐洲:不同治療，2020～2034年
- 歐洲:各終端用戶，2020～2034年
- 英國
- 法國
- 德國
- 義大利
- 西班牙
- 荷蘭
- 俄羅斯
- 其他歐洲
亞太地區
- 亞太地區:不同治療，2020～2034年
- 亞太地區:各終端用戶，2020～2034年
- 中國
- 印度
- 馬來西亞
- 日本
- 印尼
- 韓國
- 澳洲
- 其他亞太地區
中東·非洲
- 中東·非洲:不同治療，2020～2034年
- 中東·非洲:各終端用戶，2020～2034年
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 南非
- 其他中東和非洲
南美
- 南美:不同治療，2020～2034年
- 南美:各終端用戶，2020～2034年
- 墨西哥
- 巴西
- 阿根廷
- 其他南美國家

第8章競爭情形

擴大和收購的分析
- 擴大
- 收購
聯盟/合作/協定/公開

第9章企業簡介

Stemline Therapeutics(Menarini Group)
ImmunoGen, Inc.
Mustang Bio
Genentech, Inc.
Jazz Pharmaceuticals, Inc.
Cellex Patient Treatment GmbH
Xencor
Resverlogix
Celgene Corporation(Bristol-Myers Squibb)
Pfizer Inc.
Johnson & Johnson
Novartis AG

簡介目錄圖表

Product Code: PM5233

The blastic plasmacytoid dendritic cell neoplasm market size is expected to reach USD 282.81 billion by 2034, according to a new study by Polaris Market Research. The report "Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size, Share, Trends, Industry Analysis Report: By Treatment (Chemotherapy, Immunotherapy, and Stem Cell Transplantation), End Users, Region (North America, Europe, Asia Pacific, Latin America and the Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The blastic plasmacytoid dendritic cell neoplasm market is experiencing significant growth driven by increasing awareness of the disease and advancements in treatment options. Key drivers include the rising incidence of BPDCN and the development of targeted therapies and innovative treatments, such as novel drugs and immunotherapies, which are expanding the treatment landscape.

Opportunities in the market are supported by ongoing research and clinical trials aimed at improving patient outcomes and the introduction of personalized medicine approaches. Trends such as the growing emphasis on early diagnosis and the integration of next-generation sequencing techniques are also expected to shape the market. Overall, the BPDCN market is expected to grow substantially due to these factors, with a focus on improving therapeutic options and enhancing patient care.

Blastic Plasmacytoid Dendritic Cell Neoplasm Market Report Highlights

By treatment analysis, immunotherapy is the most rapidly growing segment in the BPDCN market. This is due to its promising outcomes in BPDCN treatment, driven by advancements in targeted therapies and checkpoint inhibitors. Immunotherapy is being increasingly preferred over traditional chemotherapy due to its efficacy and reduced side effects.

By end users analysis, the hospital segment dominates the market for BPDCN treatments, owing to their advanced infrastructure and comprehensive care capabilities. Specialty clinics are also seeing growth as they offer specialized treatments and patient management, reflecting a trend toward more focused care.

North America remains the largest market for BPDCN, supported by advanced healthcare infrastructure and high research activity. However, Asia Pacific is the fastest-growing region, driven by increasing investments in healthcare and rising awareness of BPDCN.

Major players actively participating in the BPDCN market include Stemline Therapeutics (now part of Menarini Group); Celgene Corporation (acquired by Bristol-Myers Squibb); Pfizer Inc., Johnson & Johnson; Novartis AG; Takeda Pharmaceutical Company Limited; Amgen Inc.; Gilead Sciences; F. Hoffmann-La Roche Ltd; Merck & Co., Inc.; AbbVie Inc.; AstraZeneca; Sanofi; Bayer AG; and Incyte Corporation.

Polaris market research has segmented the blastic plasmacytoid dendritic cell neoplasm market report based on treatment, end users, and region:

By Treatment Outlook (Revenue - USD Billion, 2020-2034)

Chemotherapy
Immunotherapy
Stem Cell Transplantation

By End Users Outlook (Revenue - USD Billion, 2020-2034)

Hospitals
Specialty Clinics
Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of the Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Insights

4.1. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Market Snapshot
4.2. Blastic Plasmacytoid Dendritic Cell Neoplasm Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Adoption of Targeted Therapies
  - 4.2.1.2. Advancements in Diagnostic Techniques
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High treatment cost
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Blastic Plasmacytoid Dendritic Cell Neoplasm Market End Use Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
5.3. Chemotherapy
- 5.3.1. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Chemotherapy, by Region, 2020-2034 (USD Million)
5.4. Immunotherapy
- 5.4.1. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Immunotherapy, by Region, 2020-2034 (USD Million)
5.5. Stem Cell Transplantation
- 5.5.1. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Stem Cell Transplantation, by Region, 2020-2034 (USD Million)

6. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
6.3. Hospitals
- 6.3.1. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Hospitals, by Region, 2020-2034 (USD Million)
6.4. Specialty Clinics
- 6.4.1. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Specialty Clinics, by Region, 2020-2034 (USD Million)
6.5. Others
- 6.5.1. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Geography

7.1. Key Findings
7.2. Introduction
- 7.2.1. Blastic Plasmacytoid Dendritic Cell Neoplasm Market Assessment, By Geography, 2020-2034 (USD Million)
7.3. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - North America
- 7.3.1. North America: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
- 7.3.2. North America: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.3.3. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - US
  - 7.3.3.1. US: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.3.3.2. US: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.3.4. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Canada
  - 7.3.4.1. Canada: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.3.4.2. Canada: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
7.4. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Europe
- 7.4.1. Europe: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
- 7.4.2. Europe: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.4.3. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - UK
  - 7.4.3.1. UK: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.4.3.2. UK: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.4.4. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - France
  - 7.4.4.1. France: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.4.4.2. France: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.4.5. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Germany
  - 7.4.5.1. Germany: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.4.5.2. Germany: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.4.6. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Italy
  - 7.4.6.1. Italy: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.4.6.2. Italy: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.4.7. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Spain
  - 7.4.7.1. Spain: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.4.7.2. Spain: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.4.8. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Netherlands
  - 7.4.8.1. Netherlands: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.4.8.2. Netherlands: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.4.9. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Russia
  - 7.4.9.1. Russia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.4.9.2. Russia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.4.10. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Rest of Europe
  - 7.4.10.1. Rest of Europe: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.4.10.2. Rest of Europe: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
7.5. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Asia Pacific
- 7.5.1. Asia Pacific: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
- 7.5.2. Asia Pacific: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.5.3. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - China
  - 7.5.3.1. China: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.5.3.2. China: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.5.4. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - India
  - 7.5.4.1. India: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.5.4.2. India: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.5.5. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Malaysia
  - 7.5.5.1. Malaysia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.5.5.2. Malaysia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.5.6. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Japan
  - 7.5.6.1. Japan: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.5.6.2. Japan: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.5.7. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Indonesia
  - 7.5.7.1. Indonesia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.5.7.2. Indonesia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.5.8. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - South Korea
  - 7.5.8.1. South Korea: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.5.8.2. South Korea: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.5.9. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Australia
  - 7.5.9.1. Australia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.5.9.2. Australia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.5.10. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Rest of Asia Pacific
  - 7.5.10.1. Rest of Asia Pacific: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.5.10.2. Rest of Asia Pacific: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
7.6. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
- 7.6.2. Middle East & Africa: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.6.3. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Saudi Arabia
  - 7.6.3.1. Saudi Arabia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.6.3.2. Saudi Arabia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.6.4. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - UAE
  - 7.6.4.1. UAE: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.6.4.2. UAE: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.6.5. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Israel
  - 7.6.5.1. Israel: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.6.5.2. Israel: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.6.6. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - South Africa
  - 7.6.6.1. South Africa: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.6.6.2. South Africa: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.6.7. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Rest of Middle East & Africa
  - 7.6.7.1. Rest of Middle East & Africa: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.6.7.2. Rest of Middle East & Africa: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
7.7. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Latin America
- 7.7.1. Latin America: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
- 7.7.2. Latin America: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.7.3. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Mexico
  - 7.7.3.1. Mexico: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.7.3.2. Mexico: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.7.4. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Brazil
  - 7.7.4.1. Brazil: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.7.4.2. Brazil: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.7.5. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Argentina
  - 7.7.5.1. Argentina: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.7.5.2. Argentina: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
- 7.7.6. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Rest of Latin America
  - 7.7.6.1. Rest of Latin America: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  - 7.7.6.2. Rest of Latin America: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Stemline Therapeutics (Menarini Group)
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. ImmunoGen, Inc.
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. Mustang Bio
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Genentech, Inc.
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. Jazz Pharmaceuticals, Inc.
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. Cellex Patient Treatment GmbH
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. Xencor
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. Resverlogix
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. Celgene Corporation (Bristol-Myers Squibb)
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
9.10. Pfizer Inc.
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
9.11. Johnson & Johnson
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
9.12. Novartis AG
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development

簡介目錄圖表

List of Tables:

Table 1 Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 2 Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 3 North America: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 4 North America: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 5 US: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 6 US: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 7 Canada: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 8 Canada: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 9 Europe: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 10 Europe: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 11 UK: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 12 UK: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 13 France: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 14 France: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 15 Germany: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 16 Germany: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 17 Italy: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 18 Italy: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 19 Spain: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 20 Spain: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 21 Netherlands: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 22 Netherlands: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 23 Russia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 24 Russia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 25 Rest of Europe: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 26 Rest of Europe: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 27 Asia Pacific: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 28 Asia Pacific: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 29 China: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 30 China: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 31 India: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 32 India: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 33 Malaysia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 34 Malaysia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 35 Japan: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 36 Japan: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 37 Indonesia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 38 Indonesia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 39 South Korea: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 40 South Korea: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 41 Australia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 42 Australia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 43 Rest of Asia Pacific: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 44 Rest of Asia Pacific: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 45 Middle East & Africa: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 46 Middle East & Africa: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 47 Saudi Arabia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 48 Saudi Arabia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 49 UAE: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 50 UAE: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 51 Israel: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 52 Israel: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 53 South Africa: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 54 South Africa: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 55 Rest of Middle East & Africa: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 56 Rest of Middle East & Africa: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 57 Latin America: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 58 Latin America: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 59 Mexico: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 60 Mexico: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 61 Brazil: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 62 Brazil: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 63 Argentina: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 64 Argentina: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
Table 65 Rest of Latin America: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
Table 66 Rest of Latin America: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
List of Figures:
Figure 1. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, 2020-2034 (USD Million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Treatment
Figure 7. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2024 & 2034 (USD Million)
Figure 8. Market by End Use
Figure 9. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2024 & 2034 (USD Million)